Lanreotide acetate and Type 2 diabetes - a phase IV clinical study of FDA data

Summary:

Type 2 diabetes is reported as a side effect among people who take Lanreotide acetate (lanreotide acetate), especially for people who are male, 60+ old, also take Afinitor, and have Neuroendocrine tumor.

The phase IV clinical study analyzes which people have Type 2 diabetes when taking Lanreotide acetate. It is created by eHealthMe based on reports of 2,168 people who have side effects when taking Lanreotide acetate from the FDA, and is updated regularly.

What is Lanreotide acetate?

Lanreotide acetate has active ingredients of lanreotide acetate. eHealthMe is studying from 2,168 Lanreotide acetate users. Check the latest studies of Lanreotide acetate.

What is Type 2 diabetes?

Type 2 diabetes is found to be associated with 1,433 drugs and 2,345 conditions by eHealthMe. Check the latest studies of Type 2 diabetes.

On Jul, 15, 2026

2,168 people reported to have side effects when taking Lanreotide acetate.
Among them, 13 people (0.6%) have Type 2 diabetes.

Could Lanreotide acetate cause Type 2 diabetes?

Among these 13 people:

What is the gender of people who have Type 2 diabetes when taking Lanreotide acetate? *

female: 30.77 %
male: 69.23 %

What is the age of people who have Type 2 diabetes when taking Lanreotide acetate? *

What are other drugs people take besides Lanreotide acetate? *

What are other side effects people have besides Type 2 diabetes? *

Fatigue (feeling of tiredness): 7 people, 53.85%
High Blood Pressure: 4 people, 30.77%
Vision Blurred: 4 people, 30.77%
Diarrhea: 4 people, 30.77%
Drowsiness: 4 people, 30.77%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 23.08%
Abdominal Pain: 3 people, 23.08%
Body Temperature Increased: 3 people, 23.08%
Dizziness: 3 people, 23.08%
Eye Swelling: 3 people, 23.08%

What are the existing conditions these people have? *

Neuroendocrine Tumor: 6 people, 46.15%
High Blood Pressure: 2 people, 15.38%
Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 2 people, 15.38%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 2 people, 15.38%
Quit Smoking: 1 person, 7.69%
Labyrinthitis (inflammation of the labyrinth or inner ear): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Lanreotide acetate and have Type 2 diabetes?

- Check whether Type 2 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lanreotide acetate:

Lanreotide acetate (2,168 reports)

Type 2 diabetes treatments and more:

Type 2 diabetes (391,582 reports)

Browse all side effects of Lanreotide acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 2 diabetes:

Type 2 diabetes (1,433 drugs)

Browse all the conditions that are associated with Type 2 diabetes:

Type 2 diabetes (2,345 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lanreotide acetate (the active ingredients of Lanreotide acetate) and Lanreotide acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.